VBI VACCINES INC's ticker is VBIV and the CUSIP is 91822J103. A total of 124 filers reported holding VBI VACCINES INC in Q4 2020. The put-call ratio across all filers is 2.75 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $6 | -33.3% | 19,784 | -18.4% | 0.00% | – |
| Q4 2022 | $9 | -99.9% | 24,252 | 0.0% | 0.00% | – |
| Q3 2022 | $17,000 | -15.0% | 24,252 | 0.0% | 0.00% | – |
| Q2 2022 | $20,000 | -60.0% | 24,252 | -18.8% | 0.00% | – |
| Q1 2022 | $50,000 | -66.7% | 29,858 | -53.5% | 0.00% | -100.0% |
| Q4 2021 | $150,000 | +48.5% | 64,278 | +98.7% | 0.00% | 0.0% |
| Q3 2021 | $101,000 | -11.4% | 32,349 | -5.2% | 0.00% | 0.0% |
| Q2 2021 | $114,000 | +44.3% | 34,124 | +34.3% | 0.00% | -66.7% |
| Q1 2021 | $79,000 | +12.9% | 25,407 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $70,000 | +1.4% | 25,407 | +4.6% | 0.00% | 0.0% |
| Q3 2020 | $69,000 | -10.4% | 24,279 | -2.1% | 0.00% | -25.0% |
| Q2 2020 | $77,000 | +266.7% | 24,810 | +13.9% | 0.00% | +300.0% |
| Q1 2020 | $21,000 | 0.0% | 21,783 | +41.7% | 0.00% | – |
| Q4 2019 | $21,000 | +200.0% | 15,377 | +6.6% | 0.00% | – |
| Q3 2019 | $7,000 | -58.8% | 14,424 | -0.6% | 0.00% | – |
| Q2 2019 | $17,000 | – | 14,514 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 55,042,465 | $171,182,000 | 2.49% |
| GENERAL AMERICAN INVESTORS CO INC | 1,877,497 | $5,839,000 | 0.50% |
| HighVista Strategies LLC | 41,271 | $129,000 | 0.08% |
| ArchPoint Investors | 65,000 | $202,000 | 0.06% |
| FIRST MIDWEST BANK TRUST DIVISION | 136,714 | $425,000 | 0.06% |
| FNY Investment Advisers, LLC | 24,683 | $76,000 | 0.04% |
| GRIMES & COMPANY, INC. | 257,960 | $802,000 | 0.04% |
| Cambridge Investment Research Advisors, Inc. | 2,065,953 | $6,425,000 | 0.03% |
| Ergoteles LLC | 171,127 | $532,000 | 0.02% |
| J.W. COLE ADVISORS, INC. | 71,100 | $221,000 | 0.02% |